Marea Therapeutics, Inc. — Form D

Marea Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-24. The offering totals $160.4M, of which $65.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-06-24
• Form: D
• Accession: 0002027714-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $160.4M
• Amount sold: $65.4M
• Remaining: $95.0M
• Investors: 10
• Date of first sale: 2024-06-11
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-516752

Issuer

• Name: Marea Therapeutics, Inc.
• CIK: 0002027714
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 135 MISSISSIPPI STREET, SAN FRANCISCO, CA, 94107
• Phone: 617-501-9046

Officers, directors & promoters (13)

More

• CIK 2027714 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search